Bharat Biotech’s Covaxin to be ready by June 2021

  • Bharat Biotech has said that Covaxin, its ICMR-backed vaccine for Covid-19, is set for launch in June 2021. The Hyderabad-based vaccine maker, which has received approval for phase 3 trials, will enroll 26,000 volunteers for the late-stage testing in November. The trials will be conducted at around 30 sites in the country.

  • The Executive Director of Bharat Biotech has said that the vaccine will be ready for launch by June 2021 unless the government authorises its emergency use.

  • Bharat biotech has enrolled 1000 volunteers for the phase-II trials and none of the participants reported any adverse side effects of the administered vaccine. The company had applied for authorisation from the DGCI to conduct phase-III trials

  • India's Zydus Cadila is currently conducting mid-stage trials of its own vaccine hopeful, while Serum Institute is making potential vaccines from AstraZeneca, Novavax and Codagenix Inc, as well as developing its own.

D9D318A1-A861-4CFD-94ED-B72F5EDD67F3_edi

Subscribe to us

Thanks for submitting!

intern%20with%20us_edited.jpg
  • Instagram
  • Twitter
  • LinkedIn
  • Facebook

INDEPENDENT.

OBJECTIVE.

UNBIASED. 

the breif bulletin logo